Rv0006 - c.1635G>A
Drug resistance types
3 Sensitive
1 RR-TB
8 HR-TB
4 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
8 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 7 |
| lineage3 | 2 |
| La1;lineage4.1.2 | 1 |
| lineage2.2.1.2 | 1 |
| lineage4.3.2;lineage4.9 | 1 |
| La3;lineage4.3.4 | 1 |
| La2;lineage4.9;lineage9 | 1 |
| lineage6.1.1 | 2 |
| 1 | |
| lineage4.9;lineage6.3 | 1 |
| lineage4.9;lineage9 | 1 |
| lineage3.1.2.2 | 1 |
| lineage4.6.3;lineage4.9 | 1 |
| lineage2.1;lineage4.9;lineage6.3 | 1 |
| La3;lineage4.1.2.1;lineage4.2.1;lineage4.5;lineage4.9;lineage6.1.1;lineage6.3.2 | 1 |
| La3;lineage4.9 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 24 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | ERR4821655 | HR-TB | lineage4.9 | None | ERR4798504 | RR-TB | lineage3 | None | SRR9970978 | Sensitive | La1;lineage4.1.2 | None | SRR1172796 | Sensitive | lineage2.2.1.2 | None | SRR1180226 | HR-TB | lineage4.9 | None | ERR736865 | HR-TB | lineage4.3.2;lineage4.9 | None | SRR29096410 | Other | lineage4.9 | None | SRR29097026 | Other | lineage4.9 | None | ERR161039 | HR-TB | La3;lineage4.3.4 | None | SRR29096150 | Other | lineage4.9 | None | ERR323053 | MDR-TB | La2;lineage4.9;lineage9 | None | ERR3799304 | Other | lineage6.1.1 | None | SRR1183111 | HR-TB | lineage4.9 | None | ERR987722 | MDR-TB | None | ERR502524 | HR-TB | lineage4.9;lineage6.3 | None | ERR9787014 | Other | lineage6.1.1 | None | SRR1174897 | MDR-TB | lineage4.9;lineage9 | None | ERR4798648 | MDR-TB | lineage3.1.2.2 | None | SRR8217918 | HR-TB | lineage4.9 | None | SRR14520111 | Sensitive | lineage3 | None | SRR26159047 | Other | lineage4.6.3;lineage4.9 | None | SRR23961558 | Other | lineage2.1;lineage4.9;lineage6.3 | None | ERR1034652 | Other | La3;lineage4.1.2.1;lineage4.2.1;lineage4.5;lineage4.9;lineage6.1.1;lineage6.3.2 | None | ERR181744 | HR-TB | La3;lineage4.9 | None |
|---|
